“Biotech Mergers: Evaluating Risk, Reporting, and Integration of Growth Strategies : Gilead’s Acquisition of Immunomedics: Risk and a Growth Strategy ”, AEJ, vol. 33, Mar. 2025, Accessed: Aug. 15, 2026. [Online]. Available: https://www.aejournal.com/ojs/index.php/aej/article/view/1044